Nihon Kohden Acquires 71.4% Stake in Ad‑Tech from ARCHIMED
November 26, 2024
Nihon Kohden has acquired a 71.4% stake in NeuroAdvanced Corp., the parent of Ad‑Tech Medical Instrument Corporation, from ARCHIMED’s MED II fund, with ARCHIMED retaining a 28.6% minority stake and entering a joint venture with Nihon Kohden. The deal brings together Nihon Kohden’s EEG and monitoring platform with Ad‑Tech’s intracranial neuroelectrodes to strengthen epilepsy diagnostics and expand Ad‑Tech’s global reach across North America, Europe and Asia.
- Buyers
- Nihon Kohden Corporation
- Targets
- NeuroAdvanced Corp., Ad‑Tech Medical Instrument Corporation
- Sellers
- ARCHIMED (MED II fund)
- Industry
- Medical Devices
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ARCHIMED Diagnostics Acquires 60% Stake in ARK Diagnostics
October 28, 2025
Medical Devices
ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.
-
ArchiMed Acquires Natus Medical Incorporated
July 21, 2022
Medical Devices
ArchiMed, through its MED Platform II fund, completed a take‑private acquisition of Natus Medical Incorporated, with Natus shareholders receiving $33.50 per share. ArchiMed said it will internationalize and grow Natus' neurodiagnostics product portfolio, reinforce R&D, and pursue complementary bolt‑on acquisitions.
-
ARCHIMED Acquires Majority Stake in Germany's Zyto Group
January 12, 2021
Medical Devices
ARCHIMED, through its MED II fund, has acquired a majority stake in the Zyto group — a German developer, manufacturer and distributor of advanced cancer diagnostics, including Zytomed, ZytoVision and 42 Life Sciences. The deal will keep founders and management as significant minority shareholders and is intended to accelerate product innovation, regulatory capabilities and international expansion of the group's precision oncology diagnostics.
-
ARCHIMED Acquires Majority Stake in Cardioline
November 17, 2021
Medical Devices
Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.
-
Kaizen Analytix Acquires Nihon Technology
January 19, 2026
IT Services
Kaizen Analytix has acquired Nihon Technology to strengthen its SAP, IT infrastructure, and cybersecurity capabilities while expanding its delivery footprint across Japan and India. Nihon will continue to operate with its leadership team and provide Kaizen clients expanded access to AI, advanced analytics, and large-scale data modernization services.
-
ARCHIMED Acquires 75% Stake in ActiGraph
May 18, 2020
Medical Devices
ARCHIMED (ArchiMed) has acquired a 75% stake in ActiGraph in an all-equity transaction, with management retaining 10% and other historic shareholders keeping 15%. The investment will fund ActiGraph's expansion into the regulated drug-development and clinical-trials market, accelerating product, regulatory and commercial capabilities; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.